A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors
- 7 September 2001
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 7 (5), 532-534
- https://doi.org/10.1046/j.1365-2516.2001.0537a.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Overall experience with NovoSeven®Blood Coagulation & Fibrinolysis, 2000
- NovoSeven® as a universal haemostatic agentBlood Coagulation & Fibrinolysis, 2000
- Controlling acute bleeding episodes with recombinant factor VIIa in Haemophiliacs with inhibitor: continuous infusion and bolus injectionHaemophilia, 2000
- The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patientsHaemophilia, 1999
- TAFIFibrinolysis and Proteolysis, 1999
- The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patientsHaemophilia, 1999
- Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early interventionBritish Journal of Haematology, 1999
- Clinical experience with recombinant factor VIIaBlood Coagulation & Fibrinolysis, 1998
- Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with InhibitorsThrombosis and Haemostasis, 1998
- Disarticulation of a knee joint in a haemophiliac with high inhibitor titreHaemophilia, 1996